Find out if youre eligible for the program today and get access to 1-on-1 provider visits, nutrition consultations, 24/7 customer support, and medications delivered to your door
Patients with pre-existing severe gastrointestinal conditions, including gastroparesis, should discuss these with their prescriber before starting GLP-1 medications
Yes, dose increases trigger temporary symptom recurrence because your body experiences a renewed GLP-1 receptor stimulus
On the other hand, Ozempic and Wegovy are approved for weight loss, and Wegovy is specifically indicated for people with obesity or overweight
This creates enormous variation in the market
These findings highlight the importance of cautious and rational use of widely prescribed antipyretic drugs and underscore the need for further studies to elucidate long-term safety, underlying mechanisms, and tissue-specific functional outcomes